178,95 €*
-16 % UVP 213,99 €
Versandkostenfrei per Post / DHL
Lieferzeit 2-4 Werktage
This book includes chapters written by authors with very broad backgrounds including financial, clinical, statistical, decision sciences, commercial and regulatory. Many authors have long held executive positions and have been involved with decision making at a product or at a portfolio level. As such, it is expected that this book will attract a very broad audience, including decision makers in pharmaceutical R&D, commercial and financial departments. The intended audience also includes portfolio planners and managers, statisticians, decision scientists and clinicians.
Early chapters describe approaches to portfolio optimization from big Pharma and Venture Capital standpoints. They have stronger focus on finances and processes. Later chapters present selected statistical and decision analysis methods for optimizing drug development programs and portfolios. Some methodological chapters are technical; however, with a few exceptions they require a relatively basic knowledge of statistics by a reader.
This book includes chapters written by authors with very broad backgrounds including financial, clinical, statistical, decision sciences, commercial and regulatory. Many authors have long held executive positions and have been involved with decision making at a product or at a portfolio level. As such, it is expected that this book will attract a very broad audience, including decision makers in pharmaceutical R&D, commercial and financial departments. The intended audience also includes portfolio planners and managers, statisticians, decision scientists and clinicians.
Early chapters describe approaches to portfolio optimization from big Pharma and Venture Capital standpoints. They have stronger focus on finances and processes. Later chapters present selected statistical and decision analysis methods for optimizing drug development programs and portfolios. Some methodological chapters are technical; however, with a few exceptions they require a relatively basic knowledge of statistics by a reader.
Zoran Antonijevic is a Senior Director at Cytel Consulting with responsibility for strategic advice at trial, program, or portfolio level. His research areas include: adaptive design, pharmaceutical portfolio optimization, and decision-making within clinical drug development process. Zoran has 20 years of experience in drug development. His prior experience includes positions at Harvard School of Public Health, GlaxoSmithKline, and Quintiles Innovation where his primary responsibility was to develop designs and approaches that maximize probability of success for programs and/or maximize product's value. He also has extensive experience with performing due-diligence, and as a member of product portfolio executive teams. Externally, Zoran is the chair of DIA Adaptive Design Scientific Working Group.
Addresses the impact of study design on maximizing the output at the portfolio level in the pharmaceutical industry
Examines portfolio optimization comprehensively by integrating input from multiple stakeholders
Provides an integrated approach that considers value proposition earlier in the clinical development process by incorporating marketing, commercial and medical affairs perspectives
Includes supplementary material: [...]
| Erscheinungsjahr: | 2016 |
|---|---|
| Fachbereich: | Allgemeines |
| Genre: | Recht, Sozialwissenschaften, Wirtschaft |
| Rubrik: | Recht & Wirtschaft |
| Medium: | Taschenbuch |
| Inhalt: |
viii
202 S. 14 s/w Illustr. 24 farbige Illustr. 202 p. 38 illus. 24 illus. in color. |
| ISBN-13: | 9783319343129 |
| ISBN-10: | 3319343122 |
| Sprache: | Englisch |
| Einband: | Kartoniert / Broschiert |
| Autor: | Antonijevic, Zoran |
| Redaktion: | Antonijevic, Zoran |
| Herausgeber: | Zoran Antonijevic |
| Auflage: | Softcover reprint of the original 1st edition 2015 |
| Hersteller: |
Springer Nature Switzerland
Springer International Publishing Springer International Publishing AG |
| Verantwortliche Person für die EU: | Springer Verlag GmbH, Tiergartenstr. 17, D-69121 Heidelberg, juergen.hartmann@springer.com |
| Maße: | 235 x 155 x 12 mm |
| Von/Mit: | Zoran Antonijevic |
| Erscheinungsdatum: | 23.08.2016 |
| Gewicht: | 0,33 kg |
Zoran Antonijevic is a Senior Director at Cytel Consulting with responsibility for strategic advice at trial, program, or portfolio level. His research areas include: adaptive design, pharmaceutical portfolio optimization, and decision-making within clinical drug development process. Zoran has 20 years of experience in drug development. His prior experience includes positions at Harvard School of Public Health, GlaxoSmithKline, and Quintiles Innovation where his primary responsibility was to develop designs and approaches that maximize probability of success for programs and/or maximize product's value. He also has extensive experience with performing due-diligence, and as a member of product portfolio executive teams. Externally, Zoran is the chair of DIA Adaptive Design Scientific Working Group.
Addresses the impact of study design on maximizing the output at the portfolio level in the pharmaceutical industry
Examines portfolio optimization comprehensively by integrating input from multiple stakeholders
Provides an integrated approach that considers value proposition earlier in the clinical development process by incorporating marketing, commercial and medical affairs perspectives
Includes supplementary material: [...]
| Erscheinungsjahr: | 2016 |
|---|---|
| Fachbereich: | Allgemeines |
| Genre: | Recht, Sozialwissenschaften, Wirtschaft |
| Rubrik: | Recht & Wirtschaft |
| Medium: | Taschenbuch |
| Inhalt: |
viii
202 S. 14 s/w Illustr. 24 farbige Illustr. 202 p. 38 illus. 24 illus. in color. |
| ISBN-13: | 9783319343129 |
| ISBN-10: | 3319343122 |
| Sprache: | Englisch |
| Einband: | Kartoniert / Broschiert |
| Autor: | Antonijevic, Zoran |
| Redaktion: | Antonijevic, Zoran |
| Herausgeber: | Zoran Antonijevic |
| Auflage: | Softcover reprint of the original 1st edition 2015 |
| Hersteller: |
Springer Nature Switzerland
Springer International Publishing Springer International Publishing AG |
| Verantwortliche Person für die EU: | Springer Verlag GmbH, Tiergartenstr. 17, D-69121 Heidelberg, juergen.hartmann@springer.com |
| Maße: | 235 x 155 x 12 mm |
| Von/Mit: | Zoran Antonijevic |
| Erscheinungsdatum: | 23.08.2016 |
| Gewicht: | 0,33 kg |
Ähnliche Produkte
Lieferzeit 1-2 Werktage
Lieferzeit 1-2 Wochen
Aktuell nicht verfügbar
Lieferzeit 1-2 Wochen
Lieferzeit 1-2 Wochen
Lieferzeit 4-7 Werktage
Lieferzeit 2-4 Werktage
Lieferzeit 1-2 Wochen
